These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 39106427)

  • 1. Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients: A Pilot Study.
    Docampo MJ; Batruch M; Oldrati P; Berenjeno-Correa E; Hilty M; Leventhal G; Lutterotti A; Martin R; Sospedra M
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200296. PubMed ID: 39106427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics and Paraprobiotics: Effects on Microbiota-Gut-Brain Axis and Their Consequent Potential in Neuropsychiatric Therapy.
    Mudaliar SB; Poojary SS; Bharath Prasad AS; Mazumder N
    Probiotics Antimicrob Proteins; 2024 Aug; 16(4):1440-1464. PubMed ID: 38294675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
    Wang Y; Wu G; Zhao L; Wang W
    mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of Paraprobiotics in Age-Associated Gut Dysbiosis and Neurodegenerative Diseases.
    Rahman Z; Dandekar MP
    Neuromolecular Med; 2023 Mar; 25(1):14-26. PubMed ID: 35879588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
    Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
    Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the concept of paraprobiotics: Nutraceutical/functional properties for promoting children health.
    Kumar H; Schütz F; Bhardwaj K; Sharma R; Nepovimova E; Dhanjal DS; Verma R; Kumar D; Kuča K; Cruz-Martins N
    Crit Rev Food Sci Nutr; 2023; 63(19):3943-3958. PubMed ID: 34748444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of probiotics and paraprobiotics on subjective and objective sleep metrics: a systematic review and meta-analysis.
    Irwin C; McCartney D; Desbrow B; Khalesi S
    Eur J Clin Nutr; 2020 Nov; 74(11):1536-1549. PubMed ID: 32433598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Health-Promoting Benefits of Paraprobiotics, Inactivated Probiotic Cells.
    Akter S; Park JH; Jung HK
    J Microbiol Biotechnol; 2020 Apr; 30(4):477-481. PubMed ID: 31986247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics potentials in mitigating coronavirus disease (COVID-19) pandemic.
    Reuben RC; Makut MD; Adogo LY
    Pan Afr Med J; 2021; 38():186. PubMed ID: 33995792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.
    Ailioaie LM; Litscher G
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID.
    Jurek JM; Castro-Marrero J
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD.
    Martyniak A; Medyńska-Przęczek A; Wędrychowicz A; Skoczeń S; Tomasik PJ
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraprobiotics: A New Perspective for Functional Foods and Nutraceuticals.
    Siciliano RA; Reale A; Mazzeo MF; Morandi S; Silvetti T; Brasca M
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems.
    Kanauchi O; Andoh A; AbuBakar S; Yamamoto N
    Curr Pharm Des; 2018; 24(6):710-717. PubMed ID: 29345577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.
    Liu Q; Mak JWY; Su Q; Yeoh YK; Lui GC; Ng SSS; Zhang F; Li AYL; Lu W; Hui DS; Chan PK; Chan FKL; Ng SC
    Gut; 2022 Mar; 71(3):544-552. PubMed ID: 35082169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of paraprobiotics and postbiotics to modulate the immune system: A Review.
    Mehta JP; Ayakar S; Singhal RS
    Microbiol Res; 2023 Oct; 275():127449. PubMed ID: 37454427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.